May 23, 2017 — The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6 ...
Shockwave Medical announced last week CE Mark for the company’s Coronary Lithoplasty System for the treatment of calcified plaque in conjunction with stenting in patients with coronary artery disease.
May 23, 2017 — Diagnostic and Interventional Cardiology (DAIC) won the 2017 Azbee National Bronze Award and the Regional ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and branched-graft devices, based on a report of prospectively studied patients with complex aortic aneurysm in the May edition of the Journal of Vascular Surgery.
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France. The breakthrough came on the 50th anniversary of heart transplantation.
Located along Mississippi’s Gulf Coast, Memorial Hospital at Gulfport is a nonprofit, 445-bed facility originally ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital ...
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation ...
Serelaxin failed to meet the primary endpoints of the phase 3 RELAX-AHF-2 trial, according to late-breaking results presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability ...
Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the signing of a definitive license agreement for the continued Phase III development and worldwide commercialization of flurpiridaz F-18. Flurpiridaz F-18 is an investigational positron emission tomography (PET) myocardial perfusion imaging (MPI) agent that may improve the diagnosis of coronary artery disease (CAD), the most common form of heart disease. The definitive agreement follows the signing of a term sheet previously announced in late February 2017.
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 19, 2017 — TherOx Inc. announced that it completed enrollment in the IC-HOT (Evaluation of Intracoronary Hyperoxemic ...
Nearly one-quarter of patients with a mechanical heart valve say it disturbs their sleep, according to research presented at EuroHeartCare 2017, May 18-20 in Jonkoping, Sweden.
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopkins ...